We report the isolation and characterization of a serotoninergic cell line, iC1l, derived from a mouse teratocarcinoma. The clone iCli was immortalized through the expression of the simian virus 40 oncogenes. iCli presents two states: an immature epithelial-like state (1Cli precursor) and a more differentiated state (1C01*). After induction by
dibutyryl cyclic AMP and cyclohexanecarboxylic acid, almost 100% of 1C11* cells continue to divide and have acquired a neural-like phenotype. 1Cl1* cells coexpress several neural markers, such as synaptophysin (the membrane constituent of synaptic vesicles), the neuropeptide [Met5Jenkephalin, and the neurotransmitter serotonin. iCl1* cells store endogenous serotonin and are able to synthesize serotonin from L-tryptophan and to catabolize it by monoamine oxidase B. Moreover, the cells take up serotonin by a carrier-mediated mechanism very similar to that of serotoninergic neurons. The expression of the simian virus 40 oncogenes, which promoted immortalization, does not therefore prevent further differentiation. This inducible cell line constitutes a valuable model for cellular and molecular studies concerning the physiology and the pharmacological modulation of the serotoninergic phenotype.
Study of the properties of neuronal or neuroendocrine cell types is rendered extremely difficult by the failure to isolate them from complex organs as pure, homogeneous populations of stable cells. An alternative approach is the use of immortalized cell lines to obtain a preliminary characterization and to prepare various kinds of probes. The probes can then be used to study normal cells in situ. We report here the first step in establishing such an experimental system for serotoninergic neurons: the isolation and characterization of a homogeneous clonal cell line that, upon induction, expresses a serotoninergic phenotype.
Adrenergic or cholinergic cell lines (1) (2) (3) (4) exhibiting the properties of differentiated sympathetic neurons (5) (6) (7) (8) (9) or of neuroendocrine adrenal chromaffin cells (e.g., rat pheochromocytoma line PC12) (10, 11) have been isolated. Other neural-like cells, but no clonal cell lines, expressing adrenergic or cholinergic markers have been obtained from teratocarcinomas (12) (13) (14) (15) (16) (17) .
Several models for serotoninergic neurons Other interesting models are tumors of the neuroendocrine system. Carcinoid tumors originating from enterochromaffin cells in the gut maintain a complete serotoninergic phenotype, but clonal cell lines have not been derived (22) . A cell line established from a human medullary thyroid carcinoma, MTC (23) , was recently characterized (24) . MTC cells, which originate from parafollicular cells of the thyroid, a neuralcrest derivative, maintain properties of the original cells, namely, the expression of calcitonin, calcitonin gene-related peptide, and somatostatin. The cells show many features of serotoninergic cells. However, the presence of active 5-HT uptake has not been formally demonstrated. In addition, some heterogeneity in the cell population persists even after repeated subcloning.
We have recently developed a clonal selection method that makes it possible to immortalize teratocarcinoma-derived cells that have the properties of committed cells capable of further differentiation along a restricted lineage. The method is based upon the transformation of embryonal carcinoma cells by a recombinant plasmid, pK4, that carries the early region of SV40 under the control of the adenovirus 5 ElA promoter. This promoter is active in early embryonic cells (25) . The cell line F9K4b2 was obtained after transfection by pK4 of the embryonal carcinoma F9 (26) . After in vitro differentiation of F9K4b2 was induced with retinoic acid and dibutyryl cyclic AMP (Bt2cAMP), several clones corresponding to immortalized precursors of the neuroectodermal, mesodermal, and endodermal lineages were selected (27) Cell Culture. Cells were grown as described (25 Tumor Formation. Injection of cells into syngeneic mice and processing of the tumors were as described (27) .
Immunocytochemistry. Indirect immunofluorescence studies on cells were carried out using the following monoclonal antibodies and antisera. Mouse monoclonal antibodies: Pabl9 (undiluted), detecting viral tumor (T) antigens (28) affinity-purified anti-a-fetoprotein (38); anti-fibronectin (1:20) (Cappel Laboratories).
Affinity-purified, species-specific secondary antibodies coupled to rhodamine (1:100; Nordic, Tilburg, The Netherlands) were used to visualize sites of primary antibody binding. Negative controls with omission of the primary antibody were performed in all instances.
Determination of Cellular Content of Bioactive Amines and
Neuropeptides. Cells were completely lysed by 250 hemolytic units of the purified sulfhydryl-dependent toxin alveolysin (a generous gift of J. E. Alouf, Institut Pasteur, Paris).
Unconjugated 5-HT (39), histamine (40) , and catecholamines (dopamine, norepinephrine, and epinephrine) (41) were measured radioenzymatically. Peptide (Fig. 1 A and B) , grow indefinitely in culture, maintaining a stable phenotype, and are tumorigenic in syngeneic mice.
The cell population does not express embryonal carcinoma markers or markers of extraembryonic endoderm (e.g., the extracellular matrix components laminin and type IV collagen, or a-fetoprotein) even after addition of retinoic acid, a classical inducer of embryonal carcinoma cell endoderm differentiation. Reversion towards the embryonal carcinoma state or endodermal or mesodermal differentiation has never been detected either in vitro or in the >100 tumors analyzed. The tumors (not shown) are composed of immature cells arranged in nodular structures that resemble immature neuroblastomas. In some instances, the cells are oriented around host capillaries, with an organization evocative of certain neuroendocrine tumors.
When grown in standard medium or after addition of retinoic acid, 1C11 cells exhibit an epithelial morphology (Fig. 1A) and express markers of epithelial cells such as L-CAM and the cytokeratin Endo A (Fig. 1 C and D) . This epithelial phenotype holds for up to 99o of the cell population. However, we consistently find in the cultures a few percent of round refringent cells presenting bipolar extensions. This heterogeneity is maintained after subcloning of iC11. Strikingly, after 2-3 days in the presence of Bt2cAMP, a classical inducer of neuroblastoma differentiation (8, 9) , 95-100% of the cells acquire a neural-like phenotype (Fig.   FIG. 1 (Fig. 2C ) in addition to L-CAM. Intense fibronectin immunoreactivity is observed in the cell bodies and is often concentrated at the tips of the neurites (Fig. 2F) . Synaptophysin, a membrane constituent of synaptic vesicles of neural and neuroendocrine cells (29, 30) , is found in both the cell bodies and the extensions (Fig. 2 D However, after differentiation by Bt2cAMP and cyclohexanecarboxylate, 1C11* cells acquire features of serotoninergic cells (Table 1) . Specific monoclonal antibodies revealed 5-HT both inside the cell bodies (Fig. 3A) and in the extensions. The presence of5-HT has been confirmed by biochemical measurements: Table 2 shows that 1C11* cells contain about 10 times more 5-HT than either iC11 or F9K4b2 cells.
The complete 5-HT synthetic pathway (tryptophan hydroxylase and aromatic L-amino acid decarboxylase) was found by two independent methods to be functional in both C1i1 and 1C11* but not in F9K4b2 ( Table 2 ). As calculated from Table 2 , tryptophan hydroxylase activity accounts for at least 10% of the 5-HT present in iC11* cells. As in serotoninergic neurons (47) , MAO-B activity is present (Table 2) . 1C11* cells also contain the structures required to take up 5-HT. First, specific monoclonal antibodies raised against the 5-HT transport system react with cell bodies and extensions, giving a characteristic patchy pattern (Fig. 3B) , whereas no immunoreactivity is found on iC11 cells. Second, in contrast to the precursor iC11, 1C11* cells take up Moreover, different elements of the transport machinery are functional in 1C11* cells. These include (i) the plasma membrane carrier, inhibited by paroxetine and associated with a ouabain-sensitive Na+,K+-ATPase pump; (ii) imipramine binding sites downregulating 5-HT uptake, blocked by clomipramine; and (iii) the carrier of the storage granule, sensitive to the reserpine analog Ro (Fig. 4 Right; Table 1 ). Finally, in contrast to iCi1, 1C11* cells are labeled by mepacrine (Fig. 3D) The activity of the key enzyme in 5-HT biosynthesis, tryptophan hydroxylase, is low but significant. MAO-B, the catabolic enzyme present in the serotoninergic neurons of the raphe nuclei, is also active. Both activities were also detected in the noninduced cells, confirming that they are already engaged in the serotoninergic pathway.
Four days after induction, the 5-HT content of 1C11* cells has increased 10-fold and an active uptake system has been generated that is inhibited by specific drugs and whose kinetic parameters are comparable to those of serotoninergic neurons. The 1C11* cell population is homogeneously labeled with anti-synaptophysin and anti-[Met5]enkephalin antibodies and exhibits a positive reaction with mepacrine. Such results point to the existence of secretory granules in 1C11*, which need to be characterized further by ultrastructural studies. Our data indicate that the 5-HT storage and uptake systems are qualitatively functional in lC11'* cells (Figs. 4 and 5 ; Table 2 ). This does not hold true for MTC cells Neurobioloigy: Buc-Caron et al. (24) , the most complete in vitro serotoninergic model so far, in which active, saturable uptake has not been demonstrated. MTC cells also lack MAO-B and exhibit only 1/10th the tryptophan hydroxylase activity of iC11. Most important, the MTC cell population is heterogeneous with respect to neuropeptides and 5-HT immunoreactivity.
Compared to the brain region richest in tryptophan hydroxylase activity, the raphe nuclei, 1C11* cells have a low level of this enzyme and show a low rate of 5-HT uptake. To explain this, two nonexclusive interpretations can be given. (i) The high 5-HT concentration of the culture medium (0.1-1 AM) might downregulate both the rate of 5-HT uptake and the activity of tryptophan hydroxylase. Such an explanation has been put forward for platelets (50) and MTC cells (24) . (ii) Based upon the homogeneity of the induced cell population, each 1C11* cell may contain a low number of functional carrier molecules compared to adult serotoninergic cells. High 5-HT content associated with low 5-HT uptake and tryptophan hydroxylase activity might be properties of committed, but as yet not fully differentiated, cells (51) .
In conclusion, the most remarkable feature of the 1C1l system is its inducibility. Almost 100% of the population can be induced to express [Met5]enkephalin, synaptophysin, and the serotoninergic machinery. This points to the neuronal or neuroendocrine origin of the cells (52) . Such an inducible cell line has not been available until now. The potential for proliferation and the homogeneity of the immortalized iC11 and 1C11* cells make it possible to obtain large amounts of material. This cell line constitutes a valuable tool not only for cellular and molecular studies concerning the physiology and the pharmacological modulation of the 5-HT phenotype but also for genetic studies concerning the onset of differentiation of 5-HT cells.
